Clinical trials recruiting for Leptomeningeal Metastasis From Lung Cancer
3
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 2Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Amivantamab+ systemic/ intrathecal Pemetrexed | 1 |
| Intrathecal pemetrexed | 1 |
| Methotrexate-loaded vesicles | 1 |
| proton craniospinal irradiation | 1 |
Self-screener
Recruiting trials
- Amivantamab Combined With Intrathecal Pemetrexed for LM From EGFR-Mutated Lung Adenocarcinoma
- Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal Injection for Meningeal Metastasis of Lung Cancer
- ctDNA-driven Adaptive Proton Craniospinal Irradiation in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis After Resistance to Third-Generation TKIs in the Consolidation Phase
Related conditions
Trials recruiting for Leptomeningeal Metastasis From Lung Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Leptomeningeal Metastasis From Lung Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.